Furthermore, Western blotting and RT-qPCR results indicated that inhibition of NUP85 down-regulated the expression level of CCR2 in FFA-treated AML-12 cells, while NUP85-overexpression up-regulated the expression level of CCR2 (Figure S4E-S4G). The gene discussed is CCR2; the disease is acute myeloid leukemia.